The research presented in this dissertation was conducted to answer the question: how does the cost-effectiveness of therapy with simvastatin compare with that of current cholesterol-lowering therapy and that of other generally accepted medical practices in the Netherlands?

cholesterol, coronairy heart diseases, cost-effectiveness, pharmacotherapy, prevention
F.F.H. Rutten (Frans)
Erasmus University Rotterdam
The research described in this dissertation was supported by a grant in aid from Merck & Co., Inc., Rahway, New Jersey, U.S.A.
hdl.handle.net/1765/38024
Erasmus School of Health Policy & Management (ESHPM)

Martens, L.L. (1992, June 24). The cost-effectiveness of cholesterol-lowering therapy with simvastatin in the primary prevention of coronary heart disease in the Netherlands. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/38024